Document is current
Any future updates will be listed below
-
Authors
Halpin, Sean N. https://orcid.org/0000-0001-5624-6083
Hagenaar, Doesjka A. https://orcid.org/0009-0004-9274-6316
Potter, Sarah Nelson https://orcid.org/0000-0002-8640-8992
van Wooning, Emma https://orcid.org/0009-0002-0724-3198
Gwaltney, Angela https://orcid.org/0000-0002-2305-7187
Mous, Sabine E. https://orcid.org/0000-0002-9088-8095
Wheeler, Anne C. https://orcid.org/0000-0003-2693-5616
-
Funding
Funding for this research was provided by:
Angelman Syndrome Foundation (Angelman Syndrome Foundation)
- License Information
-
More Information
Article History
Received: 3 July 2025
Accepted: 17 November 2025
First Online: 12 December 2025
Declarations
:
: The study was reviewed and approved by the Institutional Review Boards at RTI International (United States) and Erasmus Medical Center (the Netherlands).
: All participants provided informed consent before proceeding to data collection.
: AW has received funding for consulting on Angelman syndrome from Ionis, Roche, and Neuren Pharmaceuticals.
